Literature DB >> 30855747

Gasping for a Diagnosis.

Kristin D'Silva1, Sarah Brown1, Gary M Hunninghake1, Marina Vivero1, Joseph Loscalzo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30855747      PMCID: PMC7189901          DOI: 10.1056/NEJMcps1809942

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation.

Authors:  M Ikegami; T Ueda; W Hull; J A Whitsett; R C Mulligan; G Dranoff; A H Jobe
Journal:  Am J Physiol       Date:  1996-04

2.  Whole-lung lavage for pulmonary alveolar proteinosis.

Authors:  Gaëtane Michaud; Chakravarthy Reddy; Armin Ernst
Journal:  Chest       Date:  2009-12       Impact factor: 9.410

3.  Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.

Authors:  J F Seymour; J J Presneill; O D Schoch; G H Downie; P E Moore; I R Doyle; J M Vincent; K Nakata; T Kitamura; D Langton; M C Pain; A R Dunn
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

4.  An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.

Authors:  Saiprakash B Venkateshiah; Tom D Yan; Tracey L Bonfield; Mary Jane Thomassen; Moulay Meziane; Carmen Czich; Mani S Kavuru
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

5.  Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

Authors:  Ryushi Tazawa; Bruce C Trapnell; Yoshikazu Inoue; Toru Arai; Toshinori Takada; Yasuyuki Nasuhara; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masayuki Hojo; Haruyuki Ishii; Masanori Yokoba; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Yoshiko Tsuchihashi; Konosuke Morimoto; Masanori Akira; Masaki Terada; Junji Otsuka; Masahito Ebina; Chinatsu Kaneko; Toshihiro Nukiwa; Jeffrey P Krischer; Kohei Akazawa; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2010-02-18       Impact factor: 21.405

Review 6.  Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.

Authors:  Anupam Kumar; Basem Abdelmalak; Yoshikazu Inoue; Daniel A Culver
Journal:  Lancet Respir Med       Date:  2018-02-01       Impact factor: 30.700

7.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

Review 9.  Pulmonary Alveolar Proteinosis Syndrome.

Authors:  Takuji Suzuki; Bruce C Trapnell
Journal:  Clin Chest Med       Date:  2016-06-17       Impact factor: 2.878

10.  The crazy-paving pattern: a radiological-pathological correlation.

Authors:  Walter De Wever; Joke Meersschaert; Johan Coolen; Eric Verbeken; Johny A Verschakelen
Journal:  Insights Imaging       Date:  2011-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.